255 related articles for article (PubMed ID: 27865939)
1. C-reactive protein response is higher in early than in late ovarian hyperstimulation syndrome.
Korhonen KV; Savolainen-Peltonen HM; Mikkola TS; Tiitinen AE; Unkila-Kallio LS
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():162-168. PubMed ID: 27865939
[TBL] [Abstract][Full Text] [Related]
2. Plasma pentraxin 3 is higher in early ovarian hyperstimulation syndrome than in uncomplicated in vitro fertilization cycle of high-risk women.
Korhonen K; Unkila-Kallio L; Alfthan H; Hämäläinen E; Tiitinen A; Mikkola T; Tapanainen J; Savolainen-Peltonen H
Arch Gynecol Obstet; 2020 Jun; 301(6):1569-1578. PubMed ID: 32372340
[TBL] [Abstract][Full Text] [Related]
3. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
5. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
[TBL] [Abstract][Full Text] [Related]
6. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
[TBL] [Abstract][Full Text] [Related]
7. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil to lymphocyte ratio is superior to platelet to lymphocyte ratio as an early predictor of moderate/severe ovarian hyperstimulation syndrome.
Verit FF; Cetin O; Yildirim O; Keskin S; Yucel O; Yalcinkaya S
J Obstet Gynaecol; 2014 Oct; 34(7):639-43. PubMed ID: 24911966
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.
Lainas GT; Lainas TG; Venetis CA; Sfontouris IA; Zorzovilis IZ; Alexopoulou E; Tarlatzis BC; Kolibianakis EM
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):126-133. PubMed ID: 29105961
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
[TBL] [Abstract][Full Text] [Related]
11. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
[TBL] [Abstract][Full Text] [Related]
12. Effects of different doses of letrozole on the incidence of early-onset ovarian hyperstimulation syndrome after oocyte retrieval.
He Q; Liang L; Zhang C; Li H; Ge Z; Wang L; Cui S
Syst Biol Reprod Med; 2014 Dec; 60(6):355-60. PubMed ID: 25192259
[TBL] [Abstract][Full Text] [Related]
13. Serum erythropoietin level is increased during stimulation for IVF but not in OHSS.
Rekola M; Korhonen K; Unkila-Kallio L; Alfthan H; Stefanovic V; Tiitinen A; Mikkola TS; Savolainen-Peltonen H
Reprod Biol Endocrinol; 2024 Jan; 22(1):14. PubMed ID: 38243286
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
[TBL] [Abstract][Full Text] [Related]
15. [Ovarian hyperstimulation syndrome after stimulation with highly purified hMGfor in vitro fertilization: Observational study SHOview].
Barrière P; Dewailly D; Duhamel A; Gayet V
Gynecol Obstet Fertil Senol; 2017 May; 45(5):283-290. PubMed ID: 28461237
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
[TBL] [Abstract][Full Text] [Related]
17. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors.
Lyons CA; Wheeler CA; Frishman GN; Hackett RJ; Seifer DB; Haning RV
Hum Reprod; 1994 May; 9(5):792-9. PubMed ID: 7929724
[TBL] [Abstract][Full Text] [Related]
18. Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation.
Grynnerup AG; Toftager M; Zedeler A; Bogstad JW; Prætorius L; Grøndahl ML; Yding Andersen C; Sørensen S; Pinborg A; Løssl K
J Assist Reprod Genet; 2018 Dec; 35(12):2187-2193. PubMed ID: 30232642
[TBL] [Abstract][Full Text] [Related]
19. Predictive performance of peritoneal fluid in the pouch of Douglas measured five days after oocyte pick-up in predicting severe late-onset OHSS: A secondary analysis of a randomized trial.
Grynnerup AG; Løssl K; Toftager M; Bogstad JW; Prætorius L; Zedeler A; Pinborg A
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():83-87. PubMed ID: 35609351
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
